Concepedia

R. Townsend

RT

7

Publications

276

Citations

7

H-Index

2013

Active since

Affiliations

Bristol-Myers Squibb (France)(Current)

Swansea University

AstraZeneca (Sweden)

AstraZeneca (United Kingdom)

Pharmerit (Netherlands)

R. Townsend is an author at Bristol-Myers Squibb (France) specializing in medicine, outcomes research, and obesity.

Top concepts

Publications per year

2013–2017

7

Publications

7

Cost Effectiveness of Adding Dapagliflozin to Insulin for the Treatment of Type 2 Diabetes Mellitus in the Netherlands

H.G.M. van Haalen, Marjolein Pompen, Klas Bergenheim et al. · Clinical Drug Investigation · 2013 · 44 citations

, , +9

The Effect of Postexercise Carbohydrate and Protein Ingestion on Bone Metabolism

R. Townsend, Kirsty J. Elliott‐Sale, Kevin Currell et al. · Medicine & Science in Sports & Exercise · 2017 · 42 citations

Cost-effectiveness of dapagliflozin versus DPP-4 inhibitors as an add-on to Metformin in the Treatment of Type 2 Diabetes Mellitus from a UK Healthcare System Perspective

M. Charokopou, Phil McEwan, Steven Lister et al. · BMC Health Services Research · 2015 · 40 citations · Full text

Avoidance of weight gain is important for oral type 2 diabetes treatments in Sweden and Germany: Patient preferences

Ateesha F. Mohamed, J. Zhang, F. Reed Johnson et al. · Diabetes & Metabolism · 2013 · 39 citations

, , +11

Parathyroid Hormone Secretion Is Controlled by Both Ionized Calcium and Phosphate During Exercise and Recovery in Men

R. Townsend, Kirsty J. Elliott‐Sale, Ana Jéssica Pinto et al. · The Journal of Clinical Endocrinology & Metabolism · 2016 · 39 citations · Full text

Rows per page

1–5 of 7